Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday, April 30, 2026, after the New York Stock ...

San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and ...

Wondering whether ResMed at around US$220 a share looks like a bargain or a potential value trap? This article walks through what the current price actually reflects about the business. The stock has ...

ResMed is on a mission to cement the lead it’s built while competitor Philips has been out of the CPAP machine-making game. That process of building out its market share for the long-term has recently ...

ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a ...

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.

ResMed stock performance and recent context ResMed (RMD) has drawn attention after recent trading, with shares last closing at US$225.99. The stock shows a 0.6% decline over the past day and softer ...

I confess: I've been sleeping on ResMed (NYSE: RMD) stock, not paying much attention to it at all. But maybe I shouldn't ignore it -- and you may not want to, either. Here are three reasons why it's ...

Shares of ResMed Inc. RMD rallied 1.25% to $233.50 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.25% to 6,716.09 and ...

ResMed has been growing, and investing in further growth as well -- especially via digital technologies. Its stock is appealingly priced at recent levels. It's worth a closer look. First, a little ...